2019
DOI: 10.3389/fimmu.2019.01399
|View full text |Cite
|
Sign up to set email alerts
|

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor

Abstract: Myeloid-derived suppressor cells (MDSCs) play crucial roles in tumorigenesis and their inhibition is critical for successful cancer immunotherapy. MDSCs undergo metabolic reprogramming from glycolysis to fatty acid oxidation (FAO) and oxidative phosphorylation led by lipid accumulation in tumor. Increased exogenous fatty acid uptake by tumor MDSCs enhance their immunosuppressive activity on T-cells thus promoting tumor progression. Tumor-infiltrating MDSCs in mice may prefer FAO over glycolysis as a primary so… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
93
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 105 publications
(97 citation statements)
references
References 146 publications
3
93
0
Order By: Relevance
“…In mice, MDSCs are defined as cells expressing both Gr1 and CD11b markers, which can be further divided into two subpopulations: granulocytic (G)-MDSCs (CD11b + Ly6G + Ly6C low ) and monocytic (M)-MDSCs (CD11b + Ly6G − Ly6C high ). In humans, G-MDSCs are defined as CD11b + CD14 − CD15 + or HLA-DR −/low CD33 + CD14 −/low CD66b + , and M-MDSCs as CD11b + CD14 + HLA-DR −/low CD15 − or HLA-DR −/low CD33 + CD14 + CD66b − (Veglia et al, 2018;Yan et al, 2019). Despite their significance in cancer and inflammatory diseases, MDSCs remain one of the least understood subsets of leukocytes.…”
Section: Introductionmentioning
confidence: 99%
“…In mice, MDSCs are defined as cells expressing both Gr1 and CD11b markers, which can be further divided into two subpopulations: granulocytic (G)-MDSCs (CD11b + Ly6G + Ly6C low ) and monocytic (M)-MDSCs (CD11b + Ly6G − Ly6C high ). In humans, G-MDSCs are defined as CD11b + CD14 − CD15 + or HLA-DR −/low CD33 + CD14 −/low CD66b + , and M-MDSCs as CD11b + CD14 + HLA-DR −/low CD15 − or HLA-DR −/low CD33 + CD14 + CD66b − (Veglia et al, 2018;Yan et al, 2019). Despite their significance in cancer and inflammatory diseases, MDSCs remain one of the least understood subsets of leukocytes.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, tumor-derived lactate has been suggested to directly impair the cytotoxic function of NK and T cells and can control MDSC development and increase cell numbers [206][207][208]. Tumor-associated MDSCs were shown to adapt lipid metabolism as fuel via the upregulation of lipid uptake and mitochondrial fatty acid oxidation to enhance their inhibitory cytokine production in cancer [209,210]. Yet, it is still not fully understood what specific regulatory factors facilitate MDSC metabolic adaption shift from glycolysis to mitochondrial FAO for controlling their immunoinhibitory role in the tumor milieu.…”
Section: Myeloid-derived Suppressor Cells (Mdscs)mentioning
confidence: 99%
“…Tumor-invasive MDSCs uses fatty acid oxidation (FAO) as its significant source of ATP [ 46 ]. Moreover, FAO is the main metabolic fuel for producing inhibitory cytokines, and MDSCs rely on FAO to play an immunosuppressive role [ 47 , 48 ]. After tumor invasion, MDSCs increased fatty acid intake and activated FAO, leading to increased mitochondrial biosynthetic, up-regulated key enzymes of FAO, and increased oxygen consumption rate.…”
Section: Metabolism Of Mdscsmentioning
confidence: 99%